APOA5 and colorectal carcinoma: Thus, in this study, we aimed to elucidate the molecular mechanisms of PIK3CA mutation in L-OHP resistance in CRC patients, especially the alterations in the lipid metabolism related to molecule apolipoprotein A5 (APOA5), which could shed light on identifying predictive biomarkers for frontline chemotherapy options.